Aurora Cannabis Inc. to Post FY2027 Earnings of $0.05 Per Share, Atb Cap Markets Forecasts (TSE:ACB)

Aurora Cannabis Inc. (TSE:ACB) – Equities researchers at Atb Cap Markets lifted their FY2027 earnings per share (EPS) estimates for shares of Aurora Cannabis in a research report issued to clients and investors on Thursday, August 8th. Atb Cap Markets analyst F. Gomes now forecasts that the company will post earnings per share of $0.05 for the year, up from their prior forecast of $0.03. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.22) per share.

Aurora Cannabis (TSE:ACB) last issued its quarterly earnings data on Thursday, June 20th. The company reported C$0.14 earnings per share for the quarter, beating the consensus estimate of C($0.24) by C$0.38. The firm had revenue of C$67.41 million for the quarter, compared to analyst estimates of C$69.30 million. Aurora Cannabis had a negative net margin of 24.26% and a negative return on equity of 10.51%.

Separately, ATB Capital decreased their price objective on shares of Aurora Cannabis from C$12.50 to C$11.00 and set a “sector perform” rating for the company in a report on Friday, June 21st.

Aurora Cannabis Stock Performance

Shares of ACB opened at C$9.18 on Monday. The company has a quick ratio of 2.48, a current ratio of 3.42 and a debt-to-equity ratio of 17.41. Aurora Cannabis has a 12 month low of C$3.84 and a 12 month high of C$15.50. The company’s fifty day moving average is C$7.82 and its 200-day moving average is C$6.79. The firm has a market cap of C$500.77 million, a price-to-earnings ratio of -7.17 and a beta of 2.72.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.